This study will evaluate the treatment combination of pevonedistat and
This phase I/II trial studies the side effects and best dose of
This phase II trial studies the side effects of salsalate when added to venetoclax and
This phase II trial studies how well ruxolitinib phosphate and azacytidine work in treating patients with myelofibrosis or myelodysplastic syndrome/myeloproliferative neoplasm. Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in
- Researchers want to develop better ways to treat cancer. In this study, they will give people with cancer two drugs. These drugs have been used on their own to treat some blood cell cancers.
- To test the safety and efficacy of the drug combination of bortezomib and clofarabine.
- Adults age 18 and over with advanced cancer that has progressed after receiving standard treatment or that has no effective therapy.